Original articleUse of xenogenized (modified) tumor cells for treatment in experimental tumor and in human neoplasia
References (66)
- et al.
Drug-mediated increase of susceptibility of human lung cancer to NK or LAK effector cells
Immunopharmacology
(1991) - et al.
Untreated or drug-treated tumor cells are differentially recognized by allogeneic lymphocytes
Int J Immunopharmacol
(1994) - et al.
THF-gamma2, a synthetic thymic hormone, increases effectiveness of combined chemotherapy and immunotherapy against RPC-5 murine plasmacytoma
Int J Immunopharmacol
(1990) - et al.
Preparation of highly immunogenic conjugates by direct coupling to glutaraldehydetreated cells: comparison with commonly used preparations
J Immunol Methods
(1981) - et al.
Prevention treatment of L1210 mouse leukemia with xenogenized tumor cells combined with immunostimulation by the P40 fraction of C. granulosum and chemotherapy
Int J Immunopharmacol
(1984) - et al.
Cell mediated immunity to chemically xenogenized tumors. II. Evidence for accessory function and self-antigen presentation by a highly immunogenic tumor variant
Cell Immunol
(1988) - et al.
JOMOL-immunostimulation and rejection of tumor cells?
Schweiz Rundsch Med Prax
(1997) - et al.
Two antiemetic regimens do not impair chemical xenogenization induced in vivo by 5(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide
Cancer Chemother Pharmacol
(1989) Genemodified tumor cells as cellular vaccines
Cancer Immunol Immunother
(1996)- et al.
Immunotherapy trials with neuraminidase modified tumor cells
A retroviral virus encoded by mutated env p15E gene is recognized by specific CD8+ lymphocytes on drug-treated murine mastocytoma P815
1nt J Immunopharmacol
(1996)
Tumor immuno prophylaxis in mice using glutaraldehyde-treated syngeneic myeloma cells
Br J Cancer
(1981)
Immunity to lymphoid tumors induced in syngeneic mice by immunization with mitomycin-C-treated cells
J Immunol
(1977)
Treatment of human melanoma with a hapten-modified autologous vaccine
Ann NY Acad Sci
(1993)
Association of tumorigenic and nontumorigenic (immunogenic) variants in a mouse T-cell lymphoma with two distinct p53 mutations
Mol Carcinog
(1993)
Antigenic changes of L1210 leukemic in mice treated with 5(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide
Cancer Res
(1972)
Immuno-logical alterations of leukemic cells in vivo after treatment with an antitumor drug
Enhanced expression of class I major histocompatibility complex gene (Dk) products on immunogenic variants of a spontaneous murine carcinoma
J Natl Cancer Inst
(1985)
Xenogenization as a new approach to cancer immunotherapy
Antigenic changes of a murine lymphoma by in vivo treatment with triazine derivatives
Cancer Immunol Immunother
(1981)
In vivo characterization of immunogenicity of a mitoxantrone-resistant murine P388 leukemia
In Vivo
(1993)
Chemical xenogenization: antigenic changes of cancer cells induced by triazine compounds
Contrib Gynecol Obstet
(1991)
06-alkylguanine-DNA alkyltransferase attenuates triazene-induced cytotoxicity and tumor cells immunogenicity in murine L1210 leukemia
Cancer Res
(1995)
Endogenous retroviral gp70 genes of the murine lymphoma L5178Y: analysis of restriction fragment polymorphism upon induction of drug mediated immunogenicity
Viral Immunol
(1994)
Immunogenicity increase of autologous tumor cell vaccines by virus infection and attachment of bispecific antibodies
Cancer Immunol Immunother
(1996)
Artificial heterogenization of tumors by means of herpes simplex and polyoma virus
Nature (Lond)
(1964)
Active specific immunotherapy of human colorectal carcinoma with an autologous tumor cell/bacillus Calmette-Guerin vaccine
Ann NY Acad Sci
(1993)
Immunologic aspects of cancer: a review
Cancer Res
(1953)
De la serotherapie dans le traitement du cancer
CR Hebd Acad Sci
(1895)
Traitement d'un cas de sarcome par la serotherapie
CR Hebd Acad Sci
(1895)
Xenogenization of a mouse lung carcinoma (3LL) by transfection with an allogeneic class I histocompatibility complex gene (H-2Ld)
Cancer Res
(1987)
Xenogenization
Jpn J Cancer Res
(1995)
Rejectability of virus-induced tumors and nonrejectability of spontaneous tumors: a lesson in contrasts
Transplant Proc
(1977)
Cited by (4)
Chemotherapy for melanoma: The resultant of conflicting vectors
2004, Journal of Clinical OncologyCurrent status of DNA vaccines and their route of administration
2002, Critical Reviews in Therapeutic Drug Carrier Systems
Copyright © 2000 Published by Elsevier Masson SAS